This track will explore the latest breakthroughs in neuropharmacology, focusing on novel drug formulations and their mechanisms of action. Researchers are invited to present their findings on innovative therapeutic agents targeting neurological disorders.

This session will delve into the mechanisms by which neuroprotective agents exert their effects on neuronal health. Contributions that discuss both preclinical and clinical applications of these agents in various brain disorders are encouraged.

This track aims to investigate the intricate processes of neurotransmission and how pharmacological interventions can modulate these pathways. Presentations should focus on the implications of these interventions for treating neurological conditions.

This session will highlight the design, implementation, and outcomes of clinical trials focused on neurotherapeutics. Researchers are invited to share their experiences and insights regarding the challenges and successes in this field.

This track will address the current state of pharmacotherapy for neurodegenerative diseases, including Alzheimer's and Parkinson's disease. Discussions will focus on emerging therapies and their potential to alter disease progression.

This session will showcase innovative approaches in drug development specifically aimed at treating brain disorders. Contributions should emphasize novel methodologies and technologies that enhance therapeutic efficacy.